M. Kubo

发表

Portosystemic Encephalopathy without Liver Disease Masquerading as Dementia.

S. Takaki, N. Mori, K. Tsuji, 2017, Hiroshima journal of medical sciences.

Pharmacological studies on (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3-phenylpropyl)amino] propionyl]-2-oxo-imidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new ACE inhibitor: I. ACE inhibitory and anti-hypertensive activities.

R. Ishida, T. Ochiai, M. Kubo, 1990, Japanese journal of pharmacology.

[Studies on angiotensin I converting enzyme (ACE): inhibitory effect of imidapril, a novel ACE inhibitor (II). Inhibition of various tissue ACEs ex vivo].

T. Watanabe, M. Yamamura, S. Minobe, 1994, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

[Studies on angiotensin I converting enzyme (ACE) inhibitory effect of imidapril. (I). Inhibition of various tissue ACEs in vitro].

T. Watanabe, T. Taniguchi, S. Minobe, 1992, Nihon yakurigaku zasshi. Folia pharmacologica Japonica.

Pharmacological studies on TA-6366, a new ACE inhibitor: II. Effect of long-term administration from the pre-hypertensive stage on blood pressure, relative heart weight and ACE activity of various tissues in spontaneously hypertensive rats (SHRs).

R. Ishida, T. Ochiai, M. Kubo, 1991, Japanese journal of pharmacology.

Studies on angiotensin converting enzyme inhibitors. 4. Synthesis and angiotensin converting enzyme inhibitory activities of 3-acyl-1-alkyl-2-oxoimidazolidine-4-carboxylic acid derivatives.

R. Ishida, T. Ochiai, M. Kubo, 1989, Journal of medicinal chemistry.

Effects of long-term administration of (4S)-1-methyl-3-[(2S)-2-[N-((1S)-1-ethoxycarbonyl-3- phenylpropyl)amino]propionyl]-2-oxoimidazolidine-4-carboxylic acid hydrochloride (TA-6366), a new angiotensin I converting enzyme (ACE) inhibitor, from the pre-hypertensive stage on morphological change and m

R. Ishida, K. Kobayashi, M. Kubo, 1992, Journal of pharmacobio-dynamics.

Studies on Angiotensin‐Converting Enzyme Inhibitors. Part 4. Synthesis and Angiotensin‐Converting Enzyme Inhibitory Activities of 3‐Acyl‐1‐alkyl‐2‐oxoimidazolidine‐4‐carboxylic Acid Derivatives.

R. Ishida, T. Ochiai, M. Kubo, 1989 .